Abstract
Mitochondrion, the energy generating organelle of the cell, is a subject of interest for selective targeting of therapeutic molecules, both Drugs and DNA, since it is found to be involved in numerous disorders like diabetes, neurodegenerative disease and cancer etc. Mitochondrial therapy can be made possible if the bioactive molecule is selectively delivered to the mitochondria of correct cell type, using cell specific ligands and mitochondriotropic molecules in designing of cell selective mitochondria specific carrier system. In this present review we will elaborate the role of mitochondria in human disease, cell specific ligands, mitochondriotropic molecules and their utilization in construction of such cell selective and mitochondria specific delivery systems that will make mitochondrial medicine practically possible.
Keywords: Mitochondria, mitochondriotropic, targeting, ligands, mitochondrial medicine
Current Drug Delivery
Title: Cell-Selective Mitochondrial Targeting: Progress in Mitochondrial Medicine
Volume: 4 Issue: 3
Author(s): Rishi Paliwal, Shivani Rai, Bhuvaneshwar Vaidya, Sunil Mahor, Prem N. Gupta, Amit Rawat and S.P. Vyas
Affiliation:
Keywords: Mitochondria, mitochondriotropic, targeting, ligands, mitochondrial medicine
Abstract: Mitochondrion, the energy generating organelle of the cell, is a subject of interest for selective targeting of therapeutic molecules, both Drugs and DNA, since it is found to be involved in numerous disorders like diabetes, neurodegenerative disease and cancer etc. Mitochondrial therapy can be made possible if the bioactive molecule is selectively delivered to the mitochondria of correct cell type, using cell specific ligands and mitochondriotropic molecules in designing of cell selective mitochondria specific carrier system. In this present review we will elaborate the role of mitochondria in human disease, cell specific ligands, mitochondriotropic molecules and their utilization in construction of such cell selective and mitochondria specific delivery systems that will make mitochondrial medicine practically possible.
Export Options
About this article
Cite this article as:
Rishi Paliwal , Shivani Rai , Bhuvaneshwar Vaidya , Sunil Mahor , Prem N. Gupta , Amit Rawat and S.P. Vyas , Cell-Selective Mitochondrial Targeting: Progress in Mitochondrial Medicine, Current Drug Delivery 2007; 4 (3) . https://dx.doi.org/10.2174/156720107781023910
DOI https://dx.doi.org/10.2174/156720107781023910 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
Call for Papers in Thematic Issues
Advances of natural products, bio-actives and novel drug delivery system against emerging viral infections
Due to the increasing prevalence of viral infections and the ability of these human pathogens to develop resistance to current treatment strategies, there is a great need to find and develop new compounds to combat them. These molecules must have low toxicity, specific activity and high bioavailability. The most suitable ...read more
Electrospun Fibers as Drug Delivery Systems
In recent years, electrospun fibers have attracted considerable attention as potential platforms for drug delivery due to their distinctive properties and adaptability. These fibers feature a notable surface area-to-volume ratio and can be intentionally designed with high porosity, facilitating an increased capacity for drug loading and rendering them suitable for ...read more
Emerging Nanotherapeutics for Mitigation of Neurodegenerative Disorders
Conditions affecting the central nervous system (CNS) present a significant hurdle due to limited access of both treatments and diagnostic tools for the brain. The blood-brain barrier (BBB) acts as a barrier, restricting the passage of molecules from the bloodstream into the brain. The most formidable challenge facing scientists is ...read more
Nanotechnology Based Chemotherapy for the treatment of Head & Neck Cancer
The escalating recurrence rates observed in Head and Neck cancer, particularly within the chemo-therapeutically treated cohort (50-60%), can be attributed to the non-selective nature of current anticancer drug delivery modalities. In this context, nanotechnology-based drug delivery systems emerge as a promising avenue for achieving precise localization of therapeutic agents to ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
TNF-α Inhibitors with Anti-Oxidative Stress Activity from Natural Products
Current Topics in Medicinal Chemistry Recent Advances and Patents on Coronary Sinus Perfusion Devices for Treatment of Heart Disease
Recent Patents on Biomedical Engineering (Discontinued) Targeted Drug Delivery for Cardiovascular and Cerebrovascular Diseases
Current Drug Targets Therapeutic Potential of Nitrate Esters of Commonly Used Drugs
Current Topics in Medicinal Chemistry NLRP3 Is Involved in Ischemia/Reperfusion Injury
CNS & Neurological Disorders - Drug Targets Polyphenols and Stem Cells for Neuroregeneration in Parkinson’s Disease and Amyotrophic Lateral Sclerosis
Current Pharmaceutical Design The Neurovascular Unit: Focus on the Regulation of Arterial Smooth Muscle Cells
Current Neurovascular Research Human Chorionic Gonadotropin: A Model Molecule For Oligopeptide-Based Drug Discovery
Endocrine, Metabolic & Immune Disorders - Drug Targets Design, Synthesis and Biological Study of Novel NO-Donor-Caffeic Acid Hybrids as Potential Anti-Atherosclerotic Drug Candidates
Letters in Drug Design & Discovery Tyrosine Kinase Inhibitor as a new Therapy for Ischemic Stroke and other Neurologic Diseases: is there any Hope for a Better Outcome?
Current Neuropharmacology New Kid on the Block: Does Histamine Get Along with Inflammation in Amyotrophic Lateral Sclerosis?
CNS & Neurological Disorders - Drug Targets Leptin Signaling in Blood Platelets as a Target for Therapeutic Intervention
Current Signal Transduction Therapy Impact of Sphingolipid Mediators on the Determination of Cochlear Survival in Ototoxicity
Current Molecular Pharmacology Monitoring Cell Therapy Using Iron Oxide MR Contrast Agents
Current Pharmaceutical Biotechnology Advanced Glycation End Products (AGEs) and their Involvement in Liver Disease
Current Pharmaceutical Design Pulmonary Hypertension and Lung Transplantation
Current Hypertension Reviews Functional Consequences of Immune Cell Adhesion to Endothelial Cells
Current Pharmaceutical Design Histone Methylation and Transcriptional Regulation in Cardiovascular Disease
Cardiovascular & Hematological Disorders-Drug Targets Application of Resveratrol in Diabetes: Rationale, Strategies and Challenges
Current Molecular Medicine Prevention of Atherosclerosis by Interference with the Vascular Nitric Oxide System
Current Pharmaceutical Design